|   Location: Sydney, AU

Michelle is a Founding Partner and the Managing Partner at OneVentures. She serves on the investment committees of OneVentures funds and has led the capital raising activities for the firm. Her focus today is in the technology growth practice, though she has also worked extensively across both healthcare and technology investments.

With over 25 years’ experience building and investing in high growth technology companies across Australia and the US, Michelle has a proven track record in global business expansion and Australian R&D commercialisation. She has led or co-led, and served as a Director of, several landmark investments including Employment Hero ($2B valuation, 13x ROI, Returned 1.5x Fund II), Phocas (7x ROI, acq. Accel-KKR), Smart Sparrow (acq. Pearson Learning), My Mobile Data (acq. ASX:AYS), Hatchtech (Lic. to NYSE:RDY), and Vaxxas. Michelle chaired the Employment Hero board until December 2023 and continues to serve as a Director, alongside board roles at Vaxxas and Buildkite, and previously Phocas.

A current member of the Reserve Bank of Australia’s Payment Systems Board, Michelle is also a former board member of Australia’s National ICT Centre of Excellence (NICTA, now Data61), Seven West Media (ASX:SWM) and served on the NSW Government’s Digital Economy Taskforce.

In the lead up to founding OneVentures, Michelle worked for a leading family office on their alternative investments, served as an entrepreneur in residence at Southern Cross Venture Partners and was an angel investor. Prior to her investment career, Michelle was a business entrepreneur and founder, including one of Australia’s first fintech companies, E Com Industries (www.giftvouchers.com) (acq. LSE:ReD, 4.6x, 70% IRR), IT services business, Networks Beyond 2000 and a tertiary tutoring business.

Michelle is a member of the Australian Institute of Company Directors and Chief Executive Women (CEW). She was a founding advisory board member of Head Over Heels (now Apropela), supporting women entrepreneurs, and served on the advisory board of the Indigenous fund Ochre Ventures.

In addition to these roles, she lectures in the Australian Investment Council’s Foundations of Private Capital Venture Capital Course and is a Co-Founder of WinVC, a non-profit women-led initiative supporting the career trajectory of women investors in venture capital.

Michelle holds a Bachelor of Science (Honours), a Master of Science and a PhD in Applied Science.

|   BSc (Hons), MSc, PhD 

|   Healthcare

|   Location: Brisbane, AU

Sarah heads the healthcare pillar at OneVentures, focused on sourcing and supporting life sciences companies developing transformative technologies with global potential.

She currently serves as Chair of Vaxxas and Axial Therapeutics, a Board Member for Kira Biotech and an Alternate Board Member and Observer for Clinical Genomics and Prota Therapeutics.

Sarah brings over 20 years of enterprise-level leadership experience across the life sciences ecosystem, from agriculture to healthcare. Her career spans start-ups, private and public companies (ASX- and NASDAQ-listed), multinational pharma, and university research organisations. She has a strong track record in deal-making, from early-stage investments and university collaborations to major pharma transactions worth hundreds of millions of dollars.

Prior to joining OneVentures, Sarah held roles in business development and commercial strategy in Australia and the United States, combining deep scientific expertise with commercial acumen to drive innovation to market.

Sarah holds a Bachelor of Agricultural Science with First Class Honours from the University of Queensland and a Master’s in Genomics from Cornell University. She has post-graduate training in negotiation from Harvard and is a Graduate of the Australian Institute of Company Directors (GAICD). She is also a member of the QIMR Berghofer Medical Research Institute Commercial Advisory Board and the AusBiotech Investment Advisory Group.

|   BAgrSc (Hons), MPS, GAICD

| Growth Credit

| Location: Sydney, AU

Nick heads OneVentures’ Growth Credit practice and serves on the investment committees for the Growth Credit and Growth Equity funds as well as the OneVentures Board.

With nearly 20 years of experience in growth credit investing and debt advisory, he has led over $500M in financing for more than 100 companies across sectors including SaaS, PropTech, FinTech, RetailTech and MedTech. Notable investments include Fleet Space, Shippit and HomeTime.

Before joining OneVentures in 2019, Nick was a Principal at Kreos Capital, Europe’s largest growth credit fund (now part of BlackRock), where he specialised in deal origination, execution and portfolio management. He began his career at KPMG in corporate finance, focusing on debt advisory and credit transactions.

He is a mentor in the AIC Women Mentorship Program and regularly shares his insights as a keynote speaker on Growth Credit and alternative financing.

Nick holds a Bachelor of Science (Hons) from Manchester University, a Diploma in Corporate Finance from the Institute of Chartered Accountants in England and Wales and a Diploma in Treasury Management (AMCT) from the Association of Corporate Treasurers (UK).

| BSc (Hons), AMCT

|   Growth Equity

|   Location: Sydney, AU

Bevin leads OneVentures’ growth technology investment strategy for Fund V and Fund VII and serves on their Investment Committees.

With over 20 years of experience in technology investing, M&A and capital markets, Bevin provides strategic guidance to portfolio companies and sits on the boards of Lumary and MyPass. He specialises in driving growth through acquisitions, organic expansion and operational excellence.

Before joining OneVentures, Bevin was a Partner at Bailador Technology Investments, where he led growth-stage technology investments across Australia and New Zealand. During his tenure, Bailador achieved nine successful exits, delivering over $250M in returns at an average 3.1x CoC and 25% IRR. Key investments included Rezdy, RC TopCo, Standard Media Index and Updoc.

Prior to that, Bevin was Head of M&A at Catapult Group, where he led acquisitions that expanded the company’s scale and market presence globally and secured over $150M in financing. Earlier in his career, he was a graduate analyst in corporate finance at Deloitte and a vice-president in investment banking at the Royal Bank of Scotland, advising emerging companies across capital markets and M&A.

Bevin graduated with a Master of Commerce from the University of Sydney and is a Member of the Australian Institute of Company Directors.

|   MCom, USYD BCom, USYD  

|   Location: Sydney, AU

Matt is a Partner and COO at OneVentures, where he leads legal, compliance, corporate finance, investor relations and marketing functions.

As General Counsel, Company Secretary and a Responsible Manager, Matt ensures regulatory excellence and robust governance. Matt also drives ESG practices across the portfolio, supporting founders and investors by implementing effective structures, aligning with industry standards and advancing sustainability goals.

With over 20 years of legal experience in financial services, he has held senior leadership roles both locally and internationally, including General Counsel & Company Secretary at Eclipx Group and Head of Legal, Compliance and Company Secretary at ING Bank Australia. His early career includes positions at Corrs Chambers Westgarth, Perpetual and Pitcher Partners.

Matt holds a Bachelor of Laws (LLB) and a Bachelor of Business (BBus) in Banking and Finance from QUT. Admitted to the Supreme Court of NSW and the High Court of Australia, he is also a Chartered Secretary and Public Notary.

|   LLB BBus Banking & Finance 

|   Growth Equity 

|   Location: Sydney, AU

Amrita is a Growth Equity Venture Partner at OneVentures, supporting our technology portfolio companies with her operations and strategy expertise.

An experienced C-suite executive and Non-Executive Director, Amrita brings extensive expertise in strategy, operations, manufacturing, pricing, sales, and marketing across technology and healthtech companies.

Her leadership roles include serving as Co-CEO of SomnoMed (ASX: SOM) and as Chief Operating and Marketing Officer at eBay Australia.

Amrita is a Non-Executive Director at Audinate (ASX: AD8) and Genea, and has worked as a management consultant.

She holds an MBA from Harvard Business School and a Bachelor of Engineering (Biomedical).

|  BE(Hons), MBA

|   Healthcare

|   Location: United States

Jim is a Venture Partner at OneVentures, serving on the investment committee of Healthcare Fund III, a board member of BiVACOR, and an advisor to the healthcare team.

An experienced venture capitalist and former healthcare investment banker, Jim brings expertise in the biopharmaceuticals, medical devices, and diagnostics sectors of life sciences.

He served as a Managing Director and member of the Investment Committee from 2005-2017 at MPM Capital, a US$2.6 billion global venture fund focused on early-stage life sciences. He has 18 years of experience in healthcare investment banking, advising emerging growth companies on financings and strategic transactions as a Managing Director at Deutsche Bank and Thomas Weisel Partners.

Jim has served on the boards of DICE Pharmaceuticals (sold to Eli Lilly for $2.4 billion in 2023), Semma Pharmaceuticals (sold to Vertex for $950 million in 2019), and True North Therapeutics (sold to Bioverativ for $825 million in 2017).

He was appointed a Fellow at the Distinguished Career Institute at Stanford for 2017–2018. He holds an MBA, JD (Harvard).

|  MBA, JD (Harvard)

|   Growth Equity 

|   Location: United States

Jim is a Growth Equity Venture Partner at OneVentures, where he helps technology portfolio companies develop and implement their go-to-market strategies and growth initiatives.

He is a consulting advisor to portfolio companies Phocas, Shippit, and Buildkite, working closely with their CEOs and executive teams to scale operations and achieve strategic goals.

A seasoned C-suite executive, Jim has held leadership roles including GM at Fortify (acquired by HP), VP of Global Field Operations at AlienVault (acquired by AT&T), COO and CEO at CrownPeak (acquired by K1), Executive VP of Global Field Operations at Illumio, and CRO at Banyan Security (acquired by SonicWall).

Earlier in his career, he served as a Managing Director at KPMG and later Bearing Point’s High Tech Practice.

|   Growth Equity 

|   Location: United States

Mark is a Growth Equity Venture Partner at OneVentures, where he supports portfolio companies with operational improvements and US market entry strategies.

In addition, he advises our Fund VII Investment Committee, bringing extensive expertise in scaling technology companies and driving cross-border growth.

Mark is a seasoned C-suite executive with key leadership experience, including his current role as CEO of LCvista (PE-backed), and prior roles as COO of Cordance (PE-backed), and US Country Manager for Message Media, where he played a pivotal role in the company’s $1.8B exit.

Previously, he was a Principal in Portfolio Operations at Technology Crossover Ventures (TCV), providing strategic guidance to high-growth technology companies.

|  MBA

|   Growth Equity 

|   Location: Australia

Dave is a seasoned finance executive with a career spanning some of Australia’s most prominent listed companies and global multinationals. At OneVentures, he supports portfolio companies on financial strategy, capital structuring and operational performance, with a focus on scaling and maximising exit value.

OneVentures placed Dave into the CFO role at Phocas Software in 2019, where he managed Phocas’s A$45M capital raise and, alongside CEO Myles Glashier, significantly scaled the business before positioning it for exit to Accel-KKR, returning ~A$120M to OneVentures investors.

His career in senior finance spans three decades. At Vodafone, Dave held multiple leadership positions, progressing from International Financial Controller at Vodafone Europe to CFO at Vodafone Ireland and then CFO and Director of Strategy at Vodafone Australia, where he led the local negotiation team on the ~A$4B ‘3’ merger and secured A$3B in bank financing. He subsequently served as CFO at Seven West Media before taking on the same role at Network Ten, leading its sale to CBS Corporation in 2017.

Dave holds a degree from the University of Sheffield and a Diploma in Management from Henley Business School. He is a qualified Chartered Management Accountant (ACMA, CGMA) and a Graduate of the Australian Institute of Company Directors (GAICD).